MadeMed Review

MadeMed in one line: four ways to take your GLP-1, but you have to sign up to learn the price

MadeMed is a direct-to-consumer telehealth platform built around one genuinely useful idea: it sells compounded semaglutide and tirzepatide in both injectable and oral forms — four distinct products in all. That matters if you dread needles, because most GLP-1 services hand you a syringe and call it a day. MadeMed lets you pick the molecule and the format separately. The catch, and it's a real one, is that you can't see what any of it costs until you're inside the product or checkout flow. If you want a price before you hand over personal details, MadeMed will frustrate you.

How the pricing actually works (or doesn't)

MadeMed doesn't publish a monthly rate on its public pages. No headline number, no intro teaser, no posted tiers. The figure only appears once you move through the product selection or begin checkout. For context, a typical compounded GLP-1 program runs mid-three-figures a month. That's a reasonable ballpark to expect. Treat it as a guess until MadeMed shows you its own number. Before you commit, confirm three things in writing: the ongoing monthly cost after any first-month rate, whether the dose escalates in price as you titrate up, and what happens to billing if you pause.

• Get the real number first — don't assume the price you see at the lowest starter dose is what you'll pay at maintenance.
• Ask about cancellation and refunds before you order — a returns page exists at /returns, but the actual terms aren't spelled out publicly.
• Budget for the consult — telehealth platforms often bill the medical visit separately from the medication; ask whether that's bundled here.

The medications: more format choice than most rivals

The four-product menu is MadeMed's standout feature. You can choose injectable semaglutide, oral semaglutide, injectable tirzepatide, or oral tirzepatide. Tirzepatide is the dual-action drug behind the strongest weight-loss numbers in trials, and having an oral version of it on the menu is still relatively uncommon. For a needle-averse patient who specifically wants tirzepatide rather than semaglutide, that combination is hard to find elsewhere and is the single best reason to look at MadeMed.

One honest caveat on the oral compounded products: swallowed peptides are generally less efficiently absorbed than injections, so don't assume an oral pill delivers the same punch as the shot. Ask MadeMed how it doses the oral versions and what results patients typically see before you assume pill equals injection.

What MadeMed shows you — and the long list it doesn't

MadeMed displays a LegitScript certification badge on its homepage, which is a meaningful signal — LegitScript vets online pharmacies and telehealth sellers, and a fake badge is the kind of thing that gets a company in trouble fast. It also publishes a real customer-support phone line (1-800-582-1428), which is genuinely uncommon among chat-only competitors and suggests a human is reachable if something goes wrong with your order.

That's where the confident part ends. A lot of the information a careful buyer wants is simply not on MadeMed's public pages:

• No named pharmacy partner — you can't see which compounding pharmacy actually makes your medication, or whether it's a state-licensed 503A pharmacy or an FDA-registered 503B outsourcing facility.
• No state list — MadeMed doesn't publicly say where it operates, so you won't know if it serves your state until you start the flow.
• No named medical director — there's no visible clinical leadership or prescribing-physician information.
• No corporate entity or legal terms — the operating company, governing law, and arbitration venue aren't disclosed, and the standard FDA compounded-medication disclaimer isn't shown on the page.
• No public LegitScript ID — the badge is shown, but the specific certification number isn't printed where you can independently look it up.

Who should consider MadeMed — and who shouldn't

Consider it if your priority is format flexibility — specifically if you want oral tirzepatide or want the freedom to switch between pill and injection — and you're comfortable creating an account to surface pricing. The LegitScript badge and the live phone line put it a notch above the most anonymous compounding sellers.

Skip it if you want to compare costs at a glance, if you need to confirm your state is covered before investing time, or if knowing your exact pharmacy and a named medical director is non-negotiable for you. Price-transparent competitors that list their pharmacy partner and clinical team will be a better fit for cautious first-timers. You can see how we weigh transparency and oversight in our scoring methodology.

Trust and safety: good signals, thin disclosure

There are no FDA warning letters on file for MadeMed, and the LegitScript badge plus published phone support are legitimate positives. But the missing pharmacy name, undisclosed 503A-versus-503B status, absent medical director, and price opacity hold it back. It's a qualified recommendation, not a confident one. None of that means MadeMed is unsafe — it means the burden is on you to ask the questions the website doesn't answer up front.

Bottom line

MadeMed earns a look for one concrete reason: it's one of the few places offering injectable and oral versions of both semaglutide and tirzepatide, which is a real win for needle-averse patients who want choice. But it asks for a lot of trust before it gives you basic facts — no public pricing, no named pharmacy, no disclosed medical leadership. If the four-format menu is what you're after, go in with a checklist: confirm the full monthly cost, ask which pharmacy fills your prescription and under what license, and make sure your state is served. Get those answers and it can be a fair option. If it won't give them, it's a pass.

For a side-by-side, Oak ($200/month) and Collective ($59/month) are the most comparable options to weigh against MadeMed.